- Clinical Trials
- April 2024
- 80 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Clinical Trials
- January 2024
- 90 Pages
Global
From €1739EUR$1,750USD£1,446GBP
€2484EUR$2,500USD£2,065GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Report
- January 2024
- 120 Pages
Global
From €5529EUR$5,565USD£4,597GBP
€7898EUR$7,950USD£6,567GBP
- Report
- August 2024
- 186 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- June 2024
- 200 Pages
Global
From €5529EUR$5,565USD£4,597GBP
€7898EUR$7,950USD£6,567GBP
- Report
- August 2024
- 173 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- May 2024
- 176 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- May 2024
- 166 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- February 2024
- 160 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- December 2023
- 168 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- March 2024
- 200 Pages
Global
From €4123EUR$4,150USD£3,428GBP
- Clinical Trials
- June 2024
- 2468 Pages
Global
From €3427EUR$3,450USD£2,850GBP
- Report
- June 2024
- 144 Pages
Global
From €3298EUR$3,320USD£2,742GBP
€4123EUR$4,150USD£3,428GBP
- Report
- June 2024
- 144 Pages
Global
From €3298EUR$3,320USD£2,742GBP
€4123EUR$4,150USD£3,428GBP
- Report
- June 2024
- 228 Pages
Global
From €3576EUR$3,600USD£2,974GBP
The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive.
The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more